A CDK4/6-specific inhibitor palbociclib (PD033299)[10] induces premature senescence in various cancer cell types by phosphorylating and activating the transcription factor Forkhead Box M1 (FOXM1)[10–13]. Here, FOXM1 is linked to cancer.